Howard McLeod: The genomic medicine working groups, GM8 -- those
of you who are interested in GMs one through seven, there’s plenty of information on
the web, and GM8 is now starting.
And the point of all these have been trying to identify where progress is being made,
where there are gaps, trying to make certain things happen -- like, we’re working with
payers; we’ve worked with a lot of other groups at past meetings to try to really stimulate
things to happen in the field.
And with this particular working group, we -- we’re focusing on the NIH portfolio,
in particular the NHGRI portfolio, but also looking across the different ICs and identifying
where work is happening, but also where there are gaps that need to be filled.
And as Teri will show, past meetings have resulted in not only nice white papers that
were published, but also RFAs for the extramural community, intramural opportunities across
ICs, and such.
So, the goal is not to have lost two days in Bethesda, but rather to produce something
that would really go forward.
And certainly, NHGRI has a -- has a history of using these gatherings for real planning
and real implementation.
So, I think, from that standpoint, it’s going to be quite useful.
We have a lot of representation from across the United States, across North America, and
in a few cases, across the world.
And so, one of the things I’ll do to -- we can do to start is go around and introduce
ourselves.
There’ll be other opportunities to get to know each other as well throughout the day.
But I’m Howard McLeod from Moffitt Cancer Center in Tampa, Florida.
And I -- it’s freezing up here.
I’ve never been this cold since I moved down there.
[laughter]
But other than that, it’s -- I’m looking forward to the day.
And maybe we can -- we can start -- who’s down at the -- Steve, is that you down at
the end?
-- start down at the end.
Since you were getting ready to take a bite, we’ll go ahead and start with you.
[laughter]
Steven Joffe: You did that on purpose.
I’m Steve Joffe.
I’m in the Department of Medical Ethics and Health Policy at Penn.
I’m also a pediatric oncologist, and I’m involved with one of the CSER projects, the
Dana-Farber project.
Janet Williams: Janet Williams.
I am a genetic counselor at Geisinger.
I’m in the genomic medicine department.
Work on the eMERGE projects, as well as [unintelligible] funded project.
Julie Johnson: I’m Julie Johnson from University of Florida
and PI of one of the IGNITE-funded projects.
Wendy Rubinstein: Hi, I’m Wendy Rubinstein, medical geneticist
at NCBI.
Work on genetic testing registry, GTR, work on ClinVar and MedGen, and I’m also involved
in the IFCC, one of the reasons I’m here.
Stephen Kingsmore: I’m Stephen Kingsmore from Children’s
Mercy Kansas City.
And I’m the PI of one of the NSIGHT grants.
Cynthia Powell: Cynthia Powell.
I’m a clinical geneticist and pediatrician and co-PI of one of the NSIGHT grants, the
one at the University of North Carolina.
Robert Freimuth: I’m Bob Freimuth from Mayo Clinic.
I do medical informatics looking at the pharmacogenomics of clinical decision support.
I’m involved with the PGRN and eMERGE projects.
J. Michael Gaziano: I’m Mike Gaziano.
I’m DA, Boston Brigham and Women’s Hospital; Harvard Med School.
And I’m PI of the Million Veteran Program.
Dan Roden: I’m Dan Roden from Vanderbilt.
I’m -- I work on eMERGE, on the Pharmacogenetics Research Network, and I -- and I’m NHGRI
Advisory Council right now.
And I -- and I -- and I think no one has yet managed to introduce themselves without using
at least three acronyms.
[laughter]
Geoffrey Ginsburg: Geoff Ginsburg from Duke University.
I’m PI of one of the IGNITE projects --
[laughter]
-- and also a member of the GMWG for NHGRI.
[laughter]
Male Speaker: It would be hard for more [unintelligible].
Mary Relling: [laughs] I’m Mary Relling at St. Jude Children’s
Research Hospital.
I’m the incoming chair of the Pharmacogenomics Research Network, and I’m the leader of
CPIC for implementation of pharmacogenomics.
And I’m also part of the GMWG.
Marc Williams: Marc Williams.
I’m the director of the Genomic Medicine Institute at Geisinger, a member of the Genomic
Medicine Working Group, and chairing panel four.
Teri Manolio: And Howard you’ve met.
I’m Teri Manolio.
I lead the Division of Genomic Medicine here at the Genome Institute.
Rex Chisholm: Rex Chisholm, Northwestern University in Chicago,
PI of one of the eMERGE sites and also a member of the GMWG.
Carol Bult: I’m Carol Bult, professor and deputy director
of the Cancer Center at The Jackson Laboratory, Bar Harbor, Maine.
I’m on NHGRI Council and a member of the working group.
Eric Green: Eric Green, director of NHGRI.
I’ll have a few more things to say as soon as we finish going around the room introducing
ourselves.
Howard Jacob: Howard Jacob, currently at the Medical College
of Wisconsin for four weeks.
And then, I’ll be at HudsonAlpha in Huntsville, Alabama.
And I think this is hot, Howard; I think I’m in trouble.
[laughter]
I am a member of the working group and also on NHGRI Council.
Christopher Chute: Chris Chute, Johns Hopkins, PI of one of the
eMERGE grants and also on the external scientific advisory committee of IGNITE.
Alexa McCray: Alexa McCray, Harvard Medical School and one
of the PIs of the Undiagnosed Diseases Network.
Warwick Anderson: [clears throat] Excuse me.
Warwick Anderson, until recently head of the Australian National Health and Medical Research
Council, and shortly of the Human Frontier Science Program.
Ruth Brenner: Good morning.
Ruth Brenner, chief of the Air Force Medical Service personalized medicine program.
Sharon Plon: Sharon Plon, Baylor College of Medicine.
I’m one of the PIs of one of the Clinical Sequencing Exploratory Research, or CSER,
sites.
And I’m one of the ClinGen PIs.
Robert Green: Robert Green, Brigham and Women’s Hospital.
I’m primarily involved with CSER and NSIGHT and have small roles on some of the other
acronyms.
Katrina Goddard: Katrina Goddard at Kaiser Permanente Northwest
in Portland, Oregon.
I’m a PI on one of the CSER sites, and I chair the action ability work group for the
ClinGen project.
Gail Jarvik: Gail Jarvik, head of medical genetics at the
University of Washington.
I’m a PI on eMERGE and CSER and have a supporting role for the Center for Mendelian Genetics.
Heidi Rehm: Heidi Rehm from Harvard Medical School.
I’m a PI on the ClinGen project and also involved in CSER and NSIGHT.
Jonathan Berg: Jonathan Berg.
I’m a clinical geneticist at the University of North Carolina at Chapel Hill, one of the
co-PIs on a CSER project at UNC, NSIGHT project, and ClinGen.
Pierre Meulien: Good morning.
Pierre Meulien from Genome, Canada.
We run a relatively large program, Genomics and Personalized Health, in Canada.
I’d like to thank the organizers for including Canada in your deliberations.
Thank you.
And hope we have a very constructive day.
Thank you.
Gurvaneet Randhawa: Good morning.
Gurvaneet Randhawa from Agency for Healthcare Research and Quality from Rockville.
Howard McLeod: Eli, I know you’ve been here for 24 hours
or whatever at NHGRI.
But could you start off this row?
Elian Silverman: Hi, I’m Eli Silverman, and I’m a program
analyst at NHGRI.
Jacqueline Odgis: I’m Jackie Odgis.
I’m program analyst for the Genomic Medicine Working Group.
Heidi Sofia: Heidi Sofia, program director, NHGRI.
Louise Wideroff: Louise Wideroff.
And I’m a program director on detail to NHGRI.
Erin Ramos: Erin Ramos, Division of Genomic Medicine.
I’m the program director for ClinGen and PhenX.
Barbara Conley: Barb Conley.
I’m a medical oncologist, currently associate director at Cancer Diagnosis Program, and
here on behalf of the Division of Cancer Treatment and Diagnosis for a couple of NCI genomically
-- trials with genomic eligibility.
Jeffrey Struewing: Jeff Struewing, from the Division of Genomic
Medicine at NHGRI.
Annie Niehaus: Annie Niehaus, Division of Genomic Medicine.
I’m an analyst on ClinGen.
Carolyn Hutter: I’m Carolyn Hutter.
I’m also a program director in the Division of Genomic Medicine at NHGRI.
And I work primarily on the Cancer Genome Atlas and the Clinical Sequencing Exploratory
Research programs, as well as a little bit on ClinGen and some other -- oh, and the large-scale
sequencing program and some other things.
Jeffery Schloss: I’m Jeff Schloss, the director of Division
of Genome Sciences at NHGRI.
Mike Pazin: I’m Mike Pazin.
I’m a program director in Division of Genome Sciences at Genome.
Tiina Urv: I’m Tiina Urv from NICHD.
I’m a program director, along with Anastasia Wise, on the NSIGHT program.
Ebony Madden: Hi, I’m Ebony Madden.
I’m a epidemiologist at Division of Genomic Medicine and one of the program directors
for IGNITE.
Heather Junkins: I’m Heather Junkins.
I’m a program director in the Division of Genomic Medicine.
I work on the IGNITE program and the training and career programs.
Lucia Hindorff: Lucia Hindorff, Division of Genomic Medicine
program director.
I work on the CSER project, the Population Architecture using Genomics and Epidemiology,
or PAGE, program, and the GWAS Catalog.
Ken Wiley: I’m Ken Wiley, a program director, Division
of Genomic Medicine, NHGRI.
Cashell Jaquish: Cashell Jaquish.
[inaudible]
Female Speaker: [inaudible]
Howard McLeod: Well, I want to -- did we miss anyone?
Male Speaker: [inaudible]
[laughter]
Howard McLeod: [inaudible] a few others.
We’ll let them sit down.
So, I want to thank all of you for making time.
I know that some of you are on this coast for today and then zipping back to watch your
daughter graduate or other things like that.
And many of you have crossed ponds and -- big and small.
So, thank you all for your effort and for everything you’ve brought.
Maybe the three folks along here, since you’ve sat down for almost 10 seconds, could introduce
yourself before Eric makes some comments.
Sheri Schully: Hi, I’m Sheri Schully, currently of the
NCI, moving soon to the NIH OD.
Santa Tumminia: I’m Santa Tumminia, and I’m from the National
Eye Institute.
Elise Feingold: Elise Feingold, NHGRI.
[end of transcript]